Advertisement

Topics

BioMarin Pharmaceutical Company Profile

04:58 EDT 22nd March 2019 | BioPortfolio

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that:

* Address currently unmet medical needs

* Suggest a clear-cut development profile

* Provide an opportunity to be first-to-market

The company's product portfolio is comprised of three approved products and multiple investigational product candidates. [link to Preclinical product chart: 3.1] FDA-approved products include Kuvan® (sapropterin dihydrochloride) tablets for PKU, an oral small molecule therapeutic developed in partnership with Merck Serono; Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; and Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation. Investigational product candidates include PEG-PAL for the treatment of phenylketonuria (PKU), and 6R-BH4, currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease.

Location

105 Digital Drive
Novato
94949
United States of America

Contact

Phone: 415 884 6700
Fax: 415 832 7889
Email: jprice@biomarinpharm.com


News Articles [320 Associated News Articles listed on BioPortfolio]

EMA's CHMP backs approval of BioMarin's phenylketonuria drug

BioMarin Pharmaceutical's Palynziq, or pegvaliase, injection has gained a positive opinion from the European Medicines Agency -More- 

BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance ReportSummaryBioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and...

NICE refuses to endorse Biomarin’s Batten disease drug

The UK National Institute for Health and Care Excellence (NICE) has published a draft guidance saying that Biomarin’s therapy for...Read More... The post NICE refuses to endorse Biomarin’s Batten ...

BioMarin sets stage early for hemophilia cure off-Broadway

BioMarin Pharmaceutical Inc is turning to the theater to establish its name with hemophilia patients, long before its experimental cure for the bleeding disorder could reach the market.

BioMarin Pharma: EMA Adopts Positive Opinion On MAA For Palynziq Injection

WASHINGTON (dpa-AFX) - BioMarin Pharmaceutical Inc. (BMRN) announced the Committee for Medicinal Products for Human Use (CHMP), has adopted a positive opinion for the company's Marketing Authoriza...

Gene therapy firm BioMarin stages haemophilia musical

BioMarin Pharmaceutical has put on a stage musical to raise awareness about haemophilia, and determine whether creative expression helps patients, as it develops an experimental cure for the condition...

Long-Term Outlook For BioMarin Pharmaceutical

BioMarin pumps $43M into Ireland drug plant

Money will go toward adding drug product filling capabilities at the Shanbally site, where BioMarin makes its rare disease medicines Brineura and Vimizim.

Drugs and Medications [35 Associated Drugs and Medications listed on BioPortfolio]

Renal caps [cypress pharmaceutical, inc.]

Renal Caps

Naglazyme [biomarin pharmaceutical inc.]

These highlights do not include all the information needed to use NAGLAZYME safely and effectively. See full prescribing information for NAGLAZYME. NAGLAZYME (galsulfase) injection for intravenous use...

Aldurazyme [genzyme corporation]

These highlights do not include all the information needed to use ALDURAZYME safely and effectively. See full prescribing information for ALDURAZYME. ALDURAZYME (laronidase)Solution for intravenous in...

Ibuprofen [legacy pharmaceutical packaging, llc]

IBUPROFEN Tablets, USP

Cetirizine hydrochloride [bryant ranch prepack]

Cetirizine Hydrochloride Tablets, 5 mg, Allergy

PubMed Articles [445 Associated PubMed Articles listed on BioPortfolio]

IPADAM "Pharmaceutical interventions on the issue of pharmaceutical records and self-medication" quanti survey in 482 French pharmacies.

This study aims to: (i) quantify the number of pharmaceutical interventions (PIs) linked to spontaneous requests for the two oral target molecules, ibuprofen and pseudoephedrine (ii) analyse the cause...

H NMR analytical characterization of mineral oil hydrocarbons (PARAFFINS) for pharmaceutical use.

3D Printing of Pharmaceutical and Medical Applications: a New Era.

The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.

Pharmaceutical benefit managers (PBMs) are playing an increasingly important role in establishing access to pharmaceutical products for patients. PBMs set retail prices for pharmaceutical products, ne...

Fifty-eight Years and Counting: High-Impact Publishing in Computational Pharmaceutical Sciences and Mechanism-based Modeling.

Clinical Trials [348 Associated Clinical Trials listed on BioPortfolio]

Gene Therapy Study in Severe Haemophilia A Patients

This study is being conducted by Biomarin Pharmaceutical Inc. as an open label, dose escalation study in order to determine the safety and efficacy of BMN 270 (an Adenovirus-Associated Vir...

Gene Therapy Study in Severe Haemophilia A Patients With Antibodies Against AAV5

This study is being conducted by Biomarin Pharmaceutical Inc. as an open label, single dose study in order to determine the safety of valoctocogene roxaparvovec (an Adenovirus-Associated V...

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Companies [1057 Associated Companies listed on BioPortfolio]

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that: * Address currently unmet medical needs * ...

BioMarin Pharmaceutical Inc.

IBEX Technologies Incorporated

IBEX Technologies is based in Montreal in a 20,000 square foot facility, comprising of small-scale fermentation facilities, general laboratories and offices.IBEX has historically been focused on the d...

Raptor Pharmaceutical

Raptor Pharmaceutical Inc. is the culmination of years of experience and research by a consortium of scientists, investors, and creative minds with one common goal, the development of novel protein th...

More Information about "BioMarin Pharmaceutical" on BioPortfolio

We have published hundreds of BioMarin Pharmaceutical news stories on BioPortfolio along with dozens of BioMarin Pharmaceutical Clinical Trials and PubMed Articles about BioMarin Pharmaceutical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMarin Pharmaceutical Companies in our database. You can also find out about relevant BioMarin Pharmaceutical Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record